The Effect of Paracetamol and Codeine Analgesic Combination on Serum Alanine Aminotransferase and Aspartate Aminotransferase Levels in Male Wistar Rats

Authors

  • Satrio Adi Wicaksono Department of Anesthesiology and Intensive Care, Faculty of Medicine, Diponegoro University, Semarang, Indonesia https://orcid.org/0000-0001-7937-4352
  • Andi Muhammad Fatwa Mardin Department of Medicine, Faculty of Medicine, Diponegoro University, Semarang, Indonesia
  • Sulistiyati Bayu Utami Department of Cardiology and Vascular Medicine, Faculty of Medicine, Diponegoro University, Semarang, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2022.10249

Keywords:

Analgesic, Paracetamol, Codeine, Alanine aminotransferase, Aspartate aminotransferase

Abstract

BACKGROUND: Paracetamol and codeine are classified as different analgesic categories with different mechanism. The combination of both paracetamol and codeine as an analgesic works synergistically and may give better outcome in pain management in moderate-to-severe degree. However, the combination of those analgesics might bring side effects in liver.

AIM: This study was to determine the effect of analgesic combination of paracetamol and codeine on alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels of Wistar rats.

METHODS: This study was an experimental study with a pre- and post-test control group design. The study objects were 20 male Wistar rats with certain criteria, which were randomly divided into four groups, that is, control group (C), group with paracetamol therapy alone (32 mg/kgBW), group with codeine therapy alone (1.9 mg/kgBW), and group with combination therapy of paracetamol (32 mg/kgBW) and codeine (1.9 mg/kgBW). Analgesic drugs were administered orally 4 times a day for 28 days with gastric sonde. On the 29th day, blood samples were collected through retro-orbital blood vessels for measuring ALT and AST levels. Statistical tests used were one-way ANOVA and Kruskal–Wallis test.

RESULTS: They showed that there were no differences in ALT levels between C, P1, P2, and P3 in both at baseline and post-treatment. However, there were significant increases in ALT levels after treatment in comparison to baseline in the control group (C) (87.2 ± 18.43 vs. 40.6 ± 5.02; p < 0.05), P1 (78.9 ± 8.52 vs. 44.4 ± 1.14; p < 0.05), and P3 (86.4 ± 17.22 vs. 44.0 ± 1.00; p < 0.05). There were no differences in AST levels between C, P1, P2, and P3 at baseline, but there were significantly higher AST levels in P1, P2, and P3 in comparison to control at post-treatment (p < 0.05). There were no differences in AST levels between P1, P2, and P3 at post-treatment (p > 0.05). There were also significant increases in AST levels after treatment in comparison to baseline in the control group (C) (93.9 ± 1.10 vs. 37.7 ± 1.69; p < 0.05), P1 (97.6 ± 1.85 vs. 36.3 ± 1.22; p < 0.05), P2 (97.6 ± 1.70 vs. 37.7 ± 1.73; p < 0.05), and P3 (98.6 ± 0.79 vs. 36.4 ± 1.20; p < 0.05).

CONCLUSION: The combination therapy of paracetamol and codeine might not bring difference in serum ALT and AST levels compared to paracetamol therapy alone or codeine therapy alone.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Treede RD. The international association for the study of pain definition of pain: As valid in 2018 as in 1979, but in need of regularly updated footnotes. Pain Rep. 2018;3(2):e643. https://doi.org/10.1097/PR9.0000000000000643 PMid:29756089 DOI: https://doi.org/10.1097/PR9.0000000000000643

Kumar KH, Elavarasi P. Definition of pain and classification of pain disorders. J Adv Clin Res Insights. 2016;3(3):87-90. https://doi.org/10.15713/ins.jcri.112 DOI: https://doi.org/10.15713/ins.jcri.112

Ellison DL. Physiology of pain. Crit Care Nurs Clin North Am. 2017;29(4):397-406. https://doi.org/10.1016/j.cnc.2017.08.001 PMid:29107303 DOI: https://doi.org/10.1016/j.cnc.2017.08.001

Goldberg DS, McGee SJ. Pain as a global public health priority. BMC Public Health. 2011;11:770. https://doi.org/10.1186/1471-2458-11-770 PMid:21978149 DOI: https://doi.org/10.1186/1471-2458-11-770

Zaki LR, Hairi NN. A systematic review of the prevalence and measurement of chronic pain in Asian adults. Pain Manag Nurs. 2015;16(3):440-52. https://doi.org/10.1016/j.pmn.2014.08.012 PMid:25439125 DOI: https://doi.org/10.1016/j.pmn.2014.08.012

Elzahaf RA, Tashani OA, Unsworth BA, Johnson MI. The prevalence of chronic pain with an analysis of countries with a human development index of countries with a human development index less than 0.9: A systematic review without meta-analysis. Curr Med Res Opin. 2012;28(7):1221-9. https://doi.org/10.1185/03007995.2012.703132 PMid:22697274 DOI: https://doi.org/10.1185/03007995.2012.703132

Fayaz A, Croft P, Langford RM, Donaldson LJ, Jone GT. Prevalence of chronic pain in the UK: A systematic review and meta-analysis of population studies. BMJ Open. 2016;6(6):e010364. https://doi.org/10.1136/bmjopen-2015-010364 PMid:27324708 DOI: https://doi.org/10.1136/bmjopen-2015-010364

Reid KJ, Harker J, Bala MM, Truyers C, Kellen E, Bekkering GE, et al. Epidemiology of chronic non-cancer pain in Europe: Narrative review of prevalence, pain treatments and pain impact. Curr Med Res Opin. 2011;27(2):449-62. https://doi.org/10.1185/03007995.2010.545813 PMid:21194394 DOI: https://doi.org/10.1185/03007995.2010.545813

Gebhart GF, Schmidt RF. World health organization (WHO) analgesic ladder. In: Gebhart GF, Schmidt RF, editors. Encyclopedia of Pain. Berlin, Heidelberg: Springer; 2013. p. 1-10.

Raffa RB, Pergolizzi JV, Tallarida RJ Jr. Analgesic combinations. J Pain. 2010;11(8):701-9. https://doi.org/10.1016/j.jpain.2009.12.010 PMid:20338825 DOI: https://doi.org/10.1016/j.jpain.2009.12.010

Jóźwiak-Bebenista M, Nowak JZ. Paracetamol: Mechanism of action, applications and safety concern. Acta Pol Pharm. 2014;71(1):11-23. PMid:24779190

Mattia C, Coluzzi F. A look inside the association codeine-paracetamol: Clinical pharmacology. Eur Rev Med Pharmacol Sci. 2015;19(3):507-16. PMid:25720726

Peacock FW, Breitmeyer JB, Pan C, Smith WB, Royal MA. A randomized study of the efficacy and safety of intravenous acetaminophen compared to oral acetaminophen for the treatment of fever. Acad Emerg Med. 2011;18(4):360-6. https://doi.org/10.1111/j.1553-2712.2011.01043.x PMid:21496138 DOI: https://doi.org/10.1111/j.1553-2712.2011.01043.x

Larson AM, Polson J, Fontana RJ, Lalani E, Hynan LS, Schiodt FV, et al. Acetaminophen-induced acute liver failure: Results of a United States multicenter, prospective study. Hepatology. 2005;42(6):1364-72. https://doi.org/10.1002/hep.20948 PMid:16317692 DOI: https://doi.org/10.1002/hep.20948

Bhandari M, Bhandari A, Bhandari A. Recent updates on codeine. Pharm Methods. 2011;2(1):3-8. https://doi.org/10.4103/2229-4708.81082 PMid:23781422 DOI: https://doi.org/10.4103/2229-4708.81082

Ellington SP, Rosen GM. Codeine-mediated hepatotoxicity in isolated rat hepatocytes. Toxicol Appl Pharmacol. 1987;90(1):156-65. https://doi.org/10.1016/0041-008x(87)90316-4 PMid:3629588 DOI: https://doi.org/10.1016/0041-008X(87)90316-4

Singh A, Bhat TK, Sharma O. Clinical biochemistry of hepatotoxicity. J Clin Toxicol. 2011;S4;1-19. https://doi.org/10.4172/2161-0495.S4-001 DOI: https://doi.org/10.4172/2161-0495.S4-001

Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharma. 2016;7(2):27-31. https://doi.org/10.4103/0976-0105.177703 PMid:27057123 DOI: https://doi.org/10.4103/0976-0105.177703

Williams RT. Hepatic metabolism of drugs. Gut. 1972;13(7):579-85. https://doi.org/10.1136/gut.13.7.579 PMid:4403576 DOI: https://doi.org/10.1136/gut.13.7.579

Pandit A, Sachdeva T, Bafna P. Drug-induced hepatotoxicity: A review. J Appl Pharm Sci. 2012;2(5):233-43. https://doi.org/10.7324/JAPS.2012.2541 DOI: https://doi.org/10.7324/JAPS.2012.2541

Hinson JA, Roberts D, James L. Chapter 19-Mechanisms of Acetaminophen-Induced Liver Disease. In: Uetrecht J, editor. Drug-Induced Liver Disease. 3rd ed. Berlin, Heidelberg: Springer Berlin Heidelberg; 2013. p. 305-29. DOI: https://doi.org/10.1016/B978-0-12-387817-5.00019-4

Fortenberry M, Crowder J, So TY. The use of codeine and tramadol in the pediatric population-what is the verdict now? J Pediatr Health Care. 2019;33(1):117-23. https://doi.org/10.1016/j.pedhc.2018.04.016 PMid:30545525 DOI: https://doi.org/10.1016/j.pedhc.2018.04.016

Wininger SJ, Miller H, Minkowitz HS, Royal MA, Ang RY, Breitmeyer JB, et al. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery. Clin Ther. 2010;32(14):2348-69. https://doi.org/10.1016/j.clinthera.2010.12.011 PMid:21353105 DOI: https://doi.org/10.1016/j.clinthera.2010.12.011

Downloads

Published

2022-09-30

How to Cite

1.
Wicaksono SA, Mardin AMF, Utami SB. The Effect of Paracetamol and Codeine Analgesic Combination on Serum Alanine Aminotransferase and Aspartate Aminotransferase Levels in Male Wistar Rats. Open Access Maced J Med Sci [Internet]. 2022 Sep. 30 [cited 2024 Apr. 25];10(B):2267-72. Available from: https://oamjms.eu/index.php/mjms/article/view/10249